Nippon India Nifty Pharma ETF
Category: ETFs
Launch Date: 05-07-2021
AUM:
₹ 639.49 Cr
Expense Ratio
0.21%
Benchmark
NIFTY Pharma TRI
ISIN
INF204KC1089
Minimum Investment
1000.0
Minimum Topup
0.0
Minimum SIP Amount
100
Fund Manager
Himanshu Mange
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Nippon India Nifty Pharma ETF | 51.82 | - | - |
| Nifty Pharma TRI | 52.24 | 11.6 | 17.72 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
19.1776
Last change
-0.08 (-0.4151%)
Fund Size (AUM)
₹ 639.49 Cr
Performance
10.52% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.
Fund Manager
Himanshu Mange
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 24.92 |
| Dr. Reddy's Laboratories Ltd. | 11.61 |
| Cipla Ltd. | 11.29 |
| Divi's Laboratories Ltd. | 7.84 |
| Lupin Ltd. | 6.11 |
| Aurobindo Pharma Ltd. | 4.98 |
| Alkem Laboratories Ltd. | 3.73 |
| Torrent Pharmaceuticals Ltd. | 3.71 |
| Zydus Lifesciences Ltd. | 3.71 |
| Ipca Laboratories Ltd. | 2.77 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 100.0 |
| Others | 0.0 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Nippon India Nifty Pharma ETF | 0.0 |
| CPSE ETF | 27.0 |
| Motilal Oswal SP BSE Enhanced Value ETF | 0.0 |
| ICICI Pru Nifty PSU Bank ETF | 0.0 |
| Nippon India ETF Nifty PSU Bank BeES | 19.12 |
| Kotak Nifty Alpha 50 ETF | 0.0 |
| Bharat 22 ETF | 23.61 |
| ABSL Nifty 200 Momentum 30 ETF | 0.0 |
| Motilal Oswal Nifty 200 Momentum 30 ETF | 0.0 |
| ICICI Pru Nifty 200 Momentum 30 ETF | 0.0 |